Abstract: The invention pertains to a one-way valve 1, especially for medical use, comprising at least one valve housing, an inlet 22, an outlet 26, and a valve element consisting of a valve body 20 and a valve seal 16. To it make possible for the one-way valve 1 to function reliably even in the case of liquids containing dietary fiber and for the tubing assembly to be filled rapidly, it is provided according to the invention that the valve body 20 comprises a passageway 21, which opens out into a sealing cavity 23 between the valve body 20 and the valve seal 16, and that the valve seal 16 comprises an opening 39, which can be closed in such a way by the valve body 20upon relative movement of two housing parts 2, 3 that the valve seal 16 rests with a sealing lip 28 against the valve body 20.

Abstract: The invention relates to a releasable blocking system (1) of a catheter (4), comprising a base (2) adapted to receive a catheter (4), and a shell (3), mounted in rotation on the base (2) between an open position, in which the shell (3) is away from the base (2), and a closed position, in which the shell (3)is hooked on the base (2) and blocks the catheter (4) in position, in which: the system comprises an actuator (25) provided with a guide aperture (251), mobile in a housing (20) between a rest position and a blocking position, the actuator (25) comprising a first drive element (255), the shell (3)comprises a second drive element (33), adapted to cooperate with the first drive element (255) when the shell (3) is shifted from its open position to its closed position, and shift the actuator (25) to its blocking position.

Abstract: A system and method of exercising targeted muscles of the face using electrotherapy. An electrotherapy machine is provided that produces both burst mode oscillating current and biphasic current. Burst mode oscillating current is used to map positions for electrodes that cause contractions in specific regions of the targeted muscles. Biphasic current is used to map positions for electrodes that stimulate the buccal nerve branch and cause simultaneous contractions of the entire targeted muscles. After mapping burst mode oscillating current is directed from the electrotherapy machine to the first set of electrodes during a first period of time. Biphasic current is directed from the electrotherapy machine to a second set of electrodes during a second period of time that is subsequent to the first period of time. The cycles are repeated to cause concentric and eccentric contractions in the targeted muscles. The contractions exercise and tone the targeted muscles.

Abstract: A proximal end of an implantable lead may include a connector insulator having a center bore, a unitary connector pin fixedly disposed in the center bore of the connector insulator where the unitary connector pin includes a socket end configured for insertion into an electrical stimulation device and a conductor end electrically crimped to the first conductor, and a unitary ring connector having a band portion concentrically arranged around and insulated from the conductor end of the unitary connector pin and a crimp portion electrically crimped to the second conductor.

Abstract: Various embodiments concern an implantable lead. The lead can comprise a lead body. At least two conductors can extend within the lead body, such as in respective lumens of the lead body. The lead can comprise at least two electrodes. Each electrode can be connected to a respective one of the at least two conductors. A paddle body can be connected to the lead body. The paddle body can comprise a longitudinal axis that divides the paddle body into left and right sides. The at least two electrodes can be partially embedded within the paddle body. The at least two electrodes can be arrayed along the longitudinal axis. Each electrode can be asymmetric about the longitudinal axis.

Abstract: An implantable electrical stimulation lead includes a lead body, electrodes disposed along a distal end of the lead body, terminals disposed along the proximal end of the lead body, and conductors coupling the terminals to the electrodes. The electrodes include a tip electrode having an electrode body with an outer stimulating surface. An internal lumen is defined in the electrode body and extends inwardly from an opening in a proximal end of the electrode body. Side apertures are formed between the outer stimulating surface and the internal lumen. A portion of the lead body is disposed within the internal lumen and side apertures through the opening in the proximal end of the electrode body. That portion of the lead body facilitates retention of the tip electrode on a distal tip of the lead body.

Abstract: A method is provided that includes disposing midplane treatment electrodes over a superior sagittal sinus, outside and in electrical contact with a skull of a head of a subject identified as at risk of or suffering from Alzheimer's disease. Lateral treatment electrodes are disposed between 1 and 12 cm of a sagittal midplane of the skull. The subject is treated by electroosmotically driving fluid from a subarachnoid space to the superior sagittal sinus, by activating control circuitry to apply one or more treatment currents between (a) one or more of the midplane treatment electrodes and (b) one or sore of the lateral treatment electrodes. Other embodiments are also described. Other embodiments are also described.

Abstract: A system for providing non-invasive neuromodulation to a patient includes a mouthpiece and a controller. The mouthpiece includes an elongated housing, a printed circuit board, control circuitry mounted within the elongated housing, and a cable for connecting to a controller. The controller includes an elongated u-shaped element, an electronic receptacle, and a microcontroller. A method for providing non-invasive neurorehabilitation of a patient including connecting a mouthpiece to a controller, transmitting a numeric sequence to the mouthpiece, generating a first hash code, transmitting the first hash code to the controller, generating a second hash code, comparing the second hash code with the first hash code, enabling electrical communication between the mouthpiece and the controller only if the first hash code matches the second hash code, contacting the mouthpiece with the patient's intraoral cavity, and delivering neurostimulation to the patient's intraoral cavity.

Abstract: Media-exposed interconnects for transducer modules are disclosed. The transducers may be sensing transducers, actuating transducers, IC-only transducers, or combinations thereof, or other suitable transducers. The transducers may be used in connection with implantable medical devices and may be exposed to various media, such as body fluids. The media-exposed interconnects for transducer modules may allow transducers to communicate electrically with other components, such as implantable medical devices.

Abstract: A functional electrical stimulation method for rehabilitating, treating, retraining, and/or otherwise improving upper extremity mobility and control in persons having impaired or disabled upper extremities due to stroke or spinal cord injury, comprising stimulation of the lumbricalis muscles.

Abstract: The present specification discloses devices and methodologies for the treatment of GERD. Individuals with GERD may be treated by implanting a stimulation device within the patient's lower esophageal sphincter and applying electrical stimulation to the patient's lower esophageal sphincter, in accordance with certain predefined protocols. The presently disclosed devices have a simplified design because they do not require sensing systems capable of sensing when a person is engaged in a wet swallow, have improved energy storage requirements, enable improved LES function while concurrently delivering additional health benefits, and enable improved LES function post stimulation termination.

Abstract: One aspect of the present disclosure relates to a therapy delivery device for treating an obstetric or gynecological disorder other than urinary incontinence in a subject. The therapy delivery device can include a housing, at least one electrode, and a power source. The housing can be configured for implantation in a reproductive system of the subject. The at least one electrode can be connected to the housing and be configured to delivery an electrical signal to an autonomic nervous system nerve target. The power source can be in electrical communication with the at least one electrode.

Abstract: A method of using an airway treatment system for treating a dorsal displacement disorder in a horse includes generating a treatment signal configured to treat the dorsal displacement disorder, using a pacemaker processor, in order to continuously stimulate one or more muscles involved in displacing a laryngeal anatomical structure relative to an airway of the horse, and using one or more stimulation electrodes, configured to interface with tissue of the horse, to deliver the treatment signal to the tissue of the horse a period of hours every day to maintain an unobstructed airway.

Abstract: Renal function may be modulated by an implantable device having one or more leads or catheters disposed near the kidney via the lymphatic system. In one embodiment, lymphatic drainage from the kidney is modulated to increase or decrease tubular reabsorption of salt and water. The renal function modulation therapy may be delivered in an open-loop or closed-loop fashion, with the latter dependent upon a physiological variable such as blood pressure or cardiac output.

Abstract: Embodiments of the present invention provide systems and methods for the treatment of pain through activation of select neural fibers. The neural fibers may comprise one or more afferent neural fibers and/or one or more efferent neural fibers. If afferent fibers are stimulated, alone or in combination with efferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate afferent pathways in a manner approximating natural afferent activity. The afferent fibers may be associated with primary receptors of muscle spindles, golgi tendon organs, secondary receptors of muscle spindles, joint receptors, touch receptors, and other types of mechanoreceptors and/or proprioceptors. If efferent fibers are stimulated, alone or in combination with afferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate intrafusal and/or extrafusal muscle fibers, which results in an indirect activation of afferent fibers associated therewith.

Abstract: A method of operating an implantable neuromodulator includes calculating an index for each of a plurality of modulation parameter sets, wherein each modulation parameter set includes a respective plurality of modulation parameters from which the respective index is calculated, serially conveying electrical modulation energy to a patient in accordance with each of the plurality of modulation parameter sets, causing the patient to perceive paresthesia in response to the conveyance of the electrical modulation energy to the tissue in accordance with one of the plurality of modulation parameter sets, identifying the calculated index for that one modulation parameter set as a perception threshold index based on the perceived paresthesia, and storing the identified perception threshold index.

Abstract: A method and apparatus for treating a condition associated with impaired blood pressure and/or heart rate in a subject comprising applying an electrical treatment signal, wherein the electrical treatment signal is selected to at least partially block nerve impulses, or in some embodiments, to augment nerve impulses.

Abstract: A method of measuring electrically evoked auditory brainstem responses of a patient or animal body is provided. The method includes surgically implanting an auditory prosthesis having an electrode array, the electrode array positioned either intracochlear or substantially proximate a brainstem of the body. At least one electrode is stimulated in the electrode array. Electrically evoked auditory brainstem responses resulting from said stimulation are recorded using, at least in part, an electrode in the electrode array as a negative electrode, and a positive electrode positioned substantially proximate the vertex of the head of the body.

Abstract: A therapeutic neuromodulation system configured for providing therapy to a patient. The therapeutic neuromodulation system comprises a plurality of electrical terminals configured for being respectively coupled to a plurality of electrodes implanted within tissue, analog output circuitry configured for delivering therapeutic electrical energy between the plurality of electrical terminals in accordance with a set of modulation parameters that includes a defined current value, a voltage regulator configured for supplying an adjustable compliance voltage to the analog output circuitry, and control/processing circuitry configured for automatically performing a compliance voltage calibration process at a compliance voltage adjustment interval by periodically computing an adjusted compliance voltage value as a function of a compliance voltage margin.

Abstract: A neuro-stimulation system employs a includes a stimulator which may include electrode devices and/or vibration elements. A controller may be employed to drive the stimulating elements with an electrical signal. In response to the electrical signal, the stimulating elements deliver electrical and/or mechanical stimulation to the body part. The stimulation may be an aperiodic stimulation and/or may be a subthreshold stimulation. In one embodiment, the stimulator is disposable and the processor determines usage of the stimulator and ensures that the stimulator is limited to a certain amount of use. Neuro-stimulation systems may be applied to sensory cells of body parts during movement of the body parts to induce neuroplastic changes. Such movement may involve a variety of therapeutic applications, e.g. in stroke patient therapy.

Abstract: A system for delivering an electrical stimulation pulse to tissue comprises a controller-transmitter and a receiver-stimulator. The controller-transmitter includes circuitry having an energy storage capacitor. The capacitance of the energy storage capacitor is adjusted to improve the efficiency of energy delivered from the receiver-stimulator to tissue by modifying the geometry of an acoustic drive burst from the controller-transmitter.

Abstract: A rules engine acquires sensor data from sensors applied to the heart to determine the presence of a rapid heartbeat. The rules engine applies rules to the sensor data to determine whether to deliver an electrical waveform to a vagus nerve. The rules engine further determines whether an electrical waveform should be applied to the heart and, if so, the type of electrical waveform.

Abstract: Method and systems for determining the location or identify of implantable devices are disclosed. An implantable device generates an electrical output and then modifies the output at a pre-configured interval for a pre-configured period. A sensor detects the modified output and locates or identifies the implantable device based on the modified output.

Abstract: A method and apparatus for determining estimated remaining longevity for an implantable stimulator. The device employs pre-calculated numbers of days for various combinations conditions of device usage parameters to determine remaining device longevity based upon identified actual conditions of device usage and employs the determined longevity to change longevity indicator states in the device. While between longevity state changes, the device the identified conditions of device usage and adjusts the determined longevity if the conditions of use change significantly. The indicator states may correspond to one or more of Recommended Replacement Time (RRT), Elective Replacement Indicator (ERI) or End of Service (EOS).

Abstract: An apparatus may include an implantable therapy circuit that provides bi-ventricular pacing to a subject, a heart sound signal sensing circuit that produces a sensed heart sound signal that is representative of at least one heart sound associated with mechanical cardiac activity, a memory circuit to store one or more heart sound templates of cardiac capture, and a comparison circuit that compares a segment of the sensed heart sound signal to the one or more heart sound templates of cardiac capture to identify ventricles in which cardiac capture was induced by the bi-ventricular pacing. In some situations, an indication of the ventricles in which cardiac capture was induced may be generated according to the comparison.

Abstract: The present disclosure provides a cardiac pacing system. The cardiac pacing system includes a right atrial ring electrode, a right atrial tip electrode, a right ventricle ring electrode, and a pacing integrated circuit (IC) including a first pace output node electrically coupled to the right atrial ring electrode, a pace return node electrically coupled to the right atrial tip electrode, and a second pace output node electrically coupled to the right ventricle ring electrode, wherein the pacing IC has a fast discharge configuration that facilitates reducing or eliminating a DC rectification current generated from RF interference during a fast discharge phase.

Abstract: This document discusses, among other things, an implantable dielectric compartment including a channel in an outer surface of the implantable dielectric compartment, the channel configured to constrain a portion of an implantable antenna in a specific configuration along the length of the portion of the implantable antenna. In certain examples, the implantable antenna can be configured to wirelessly transfer information electromagnetically at a specified operating frequency provided using the specific configuration of the portion of the implantable antenna.

Abstract: Embodiments of the invention provide apparatus, systems and methods for harvesting energy from bio-kinetic events to power various implanted medical devices. One embodiment provides an energy harvesting mechanism for a cardiac pacemaker comprising an energy converter and a signal path component. The energy converter is positionable inside a human body and configured to generate electric power signals in response to a bio-kinetic event of the human body such as a heart beat, respiration or arterial pulse. The converter can comprise a piezoelectric material which generates electricity in response to mechanical deformation of the converter. The converter can also have a power generation characteristic that is matched to the frequency of the bio-kinetic event. For heart beat powered applications, the power generation characteristic can be matched to the physiologic range of pulse rates.

Abstract: A dynamically adjustable multiphasic pulse system and method are provided. The dynamically adjustable multiphasic pulse system may be used as pulse system for a defibrillator or cardioverter. The dynamically adjustable multiphasic pulse system may generate a positive phase and a negative phase of a pulse to generate a therapeutic pulse.

Abstract: An external defibrillator estimates the phase of ventricular defibrillation (VF) by deriving, from an ECG exhibiting VF, at least one quality marker representing the morphology of the ECG and, therefore, the duration of the VF. The duration of the VF is calculated as a function of the value (s) of the quality marker (s). The quality marker (s) may comprise any one or more of the median slope of the ECG, the average slope of the ECG, the ratio of the power in relatively high and low frequency bands of the ECG, and a measure of the density and amplitude of peaks in the ECG, over a predetermined period.

Abstract: This Invention relates to a method for achieving Focused Resonance Nanopermeabilization (FORN), which can be utilized in a novel anticancer therapy, and other selective permeabilization therapy and a machine to carryout the said method, where the transient permeabilization of cells by Focused Resonance pulses induces a significant increase of anti-tumor drug concentration in tumor or other interested cells. This invention can be successfully applied to the treatment of tumors in humans and Animals by using antimitotic drugs, chemotherapy. The invention is also useful in transpermeabilization of drug molecules for non cancer applications like vaccine and delivery of genetic materials for therapeutic purposes. Focused Resonance Nanopermeabilization (FORN), would enable a practical solution to a whole body application in its natural environment, without implanting electrodes or external probes, FORN is completely non-invasive. This invention also relates to an apparatus for carrying out the above method.

Abstract: A method of performing therapy on tissue using a medical apparatus. The apparatus includes a shaft configured for insertion into a hollow anatomical structure (HAS) and has a tissue sensor and a therapeutic energy application device both located on the shaft. The method comprises: receiving electrical power at a first power level and directing the first-level power to the tissue sensor and not to the therapeutic energy application device, thereby enabling tissue sensing with the tissue sensor; receiving electrical power at a second power level higher than the first-level power; and, in response to receipt of the second-level power, directing the second-level power to the therapeutic energy application device, thereby enabling performance of therapy on the tissue with the therapeutic energy application device. Additional methods and apparatus are disclosed as well.

Abstract: The present application is directed to the idea of using sampling techniques to propagate segmentation uncertainty in order to evaluate variability in radiation planning. A radiotherapy planning apparatus (10) creates diagnostic image data of a region of interest of a subject. Image data from other sources can also be used. The image data is segmented (44) and combined with previously imaged model data. Target measures such as dose volume histograms are produced for each of the segmentations of the image data. These measures are later combined into a statistical quantification of the target measure (FIG. 3). This information is presented (52) to the user to give the user possible outcomes of the radiotherapy plan, and, e.g., confidence levels in those outcomes.

Abstract: An integrated radiation therapy process comprises acquiring first objective target data related to a parameter of a target within a patient by periodically locating a marker positioned within the patient using a localization modality. This method continues with obtaining second objective target data related to the parameter of the target by periodically locating the marker. The first objective target data can be acquired in a first area that is apart from a second area which contains a radiation delivery device for producing an ionizing radiation beam for treating the patient. The localization modality can be the same in both the first and second areas. In other embodiments, the first objective target data can be acquired using a first localization modality that uses a first energy type to identify the marker and the second objective target data can be obtained using a second localization modality that uses a second energy.

Abstract: A radiotherapy control apparatus includes a fluoroscopic image acquisition unit to acquire fluoroscopic images of markers in a patient from a single fluoroscopic imaging device, a projection line calculation unit to identify projected positions of the markers on the fluoroscopic image and calculate equations of projection lines linking these projected positions and a focus position of the imaging device, an inter-marker distance acquisition unit to acquire a distance between each pair of the markers, a marker position calculation unit to calculate current positions of the markers based on the equations and the distances, and a therapeutic radiation emission determination unit to determine whether to emit therapeutic radiation based on the current positions of the markers.

Abstract: According to an embodiment, a treatment system includes a plurality of first radiators, a plurality of detectors, a determiner, and a controller. Each of the first radiators irradiates a radioactive beam to a subject. Each of the detectors detects a radioactive beam transmitted through the subject and generates an image based on the detected radioactive beam. The determiner determines whether an object in the subject is included in a first region using a given image that is one of the images. The controller controls the first radiators so that, when the object is not included in the first region, a smaller amount of radioactive beams is irradiated per unit time than when the object is included in the first region.

Abstract: Systems, devices, and methods for imaging-based calibration of radiation treatment couch position compensations.

Abstract: A multi-field cancer therapy apparatus and method of use thereof is described increasing dimensionality of incident tumor treatment angles while minimizing distance between a final beamline focusing magnet and the patient. Increased dimensionality of incident tumor treatment angles is achieved through coordinated use of one or more of: a rotatable targeting magnet; a first patient rotation platform rotating the patient around, without intersecting, a vertical axis; a second patient rotation platform rotating a body part through a movable vertical axis; and patient tilt. The increased charged particle incident angle dimensionality distributes Bragg peak tail energy about the tumor. Dynamic energy and/or intensity control of the charged particle beam as a function of efficiency of beam delivery based on tumor shape further reduces Bragg peak tail energy delivered to healthy tissue about the tumor.

Abstract: A water-absorbing polymer obtained from (A) a phosphate-containing (meth)acrylic monomer and/or a salt thereof, (B) a monomer having one (meth)acrylic group within the molecule and/or a salt thereof other than component (A), and (C) an organopolysiloxane having a (meth)acrylic group at both ends and related compositions.

Abstract: One of the purposes of the present invention is to provide an aqueous dispersion of silicone elastomer particles to provide a stable emulsion and the silicone elastomer particle, wherein a polyoxyethylene alkyl ether which has an alkyl group having a large number of carbon atoms is used as a surfactant. Further, another purpose is to provide a cosmetic comprising said aqueous dispersion or said silicone elastomer particles and giving a good feeling in the use. The present invention provides an aqueous dispersion comprising (A) silicone elastomer particles having a 90% volume cumulative diameter (D90) of 0.3 to 20 ?m in an amount of 5 to 80 mass %, based on a total mass of the aqueous dispersion, (B) at least one polyoxyethylene alkyl ether having an alkyl group having 18 carbon atoms in an amount of 0.01 to 15 mass %, based on a total mass of the aqueous dispersion, wherein a hydrophile-lipophile balance (HLB) of the polyoxyethylene alkyl ether is 12.8 to 15.

Abstract: A safety restraint anchor system may include, but is not limited to: a pole portion; a circumferential frame portion disposed about an axis of the pole; and at least one safety line anchor.

Abstract: The auxiliary breathing flow channel apparatus for an oxygen mask for pilots and crew of an airplane includes a flow control device with closed and open positions to regulate flow through an auxiliary channel. A pressure sensor such as an aneroid capsule automatically closes the auxiliary channel upon a decrease in cabin pressure. A handle also allows a user to manually move the flow regulating means to a closed position.

Abstract: A lightweight, low bulk, mobile CB shelter fabric includes a high tensile strength woven scrim laminated between two thin CB-impenetrable polymer films. Laminate adhesives can include isocyanate adhesion promotors. Coatings can provide camouflage, increased light opacity, increased CB protection, sun, fire, and weather resistance. Lamination heat and pressure can cause the films to conform and bond through the scrim, while a pre-applied coating does not flow and remains uniform in thickness. The resulting fabric weight can be approximately 50% of conventional CB fabrics. The films can be hard-drawn polymers. A coating of hammer milled kaolin clay can provide increased light opacity. The films can be 1 micron thick, and can be nylon, aliphatic nylon, urethane, or poly-ether. The scrim can be a 1500 denier Vectran® (liquid crystal polymer) with a 4.5 ends-per-inch warp and a 3.5 ends-per-inch fill. The scrim yarns can be flattened bundles of untwisted fiber.

Abstract: A method of making a face mask is disclosed. The method includes providing an elastic nonwoven web continuous in a machine direction, the elastic nonwoven web having a central lane extending in the machine direction; bonding a filtering web to the central lane of the elastic nonwoven web to provide a layered web, the filtering web being continuous in the machine direction and having a cross-web width that is substantially the same as the cross-web width of the central lane; and stamping a face mask into the layered web. A face mask and a continuous layered web having a plurality of face masks disposed thereon are also disclosed.

Abstract: Fire block devices for application to a wall component. The fire-block device can be a wall component that includes a fire-resistant material strip that expands in response to sufficient heat to create a fire-resistant barrier. In some applications, the fire-block wall component is positioned to extend lengthwise along and across a gap between wallboard members. The fire-block wall component may have a U-shaped central portion and a pair of side portions extending in opposite directions from the central portion. The fire-resistant material may be positioned on the central portion of the fire-block device. The central portion may be positioned within the gap such that the fire-resistant material expands in response to sufficient heat to create a fire-resistant barrier.

Abstract: A barrier assembly comprising a horizontally deployable vapor barrier assembly with a frame with opposing side guides extending between a header and footer. A guide rod contained in each side guide extends between the header and the footer. A vapor barrier is deployable horizontally with side edge sleeve portions that slide axially over the guide rods. At least one roller is connected to each of the side guides adjacent to the guide rod, and each roller supports a portion of the vapor barrier's side edge portions. The rollers rolls on the edge portions as the sleeve portion slides axially over the guide rods as the vapor barrier moves between the deployed and stowed positions. Lifter plates are attached to each of the side guides and positioned to engage support carriages and temporarily lift the support member out of engagement with the support surface over segment joints as the vapor barrier moves between the stowed and deployed positions.

Abstract: A fireman shield assembly for inhibiting a fireman from being struck by falling, burning debris includes a frame that may be positioned around a fireman. A shield is positioned over the frame. The covers the fireman when the fireman stands in the frame. Thus, the shield inhibits falling debris from striking the fireman.

Abstract: A corrosion prevention treatment of wet Fire Protection System (FPS) includes purging the pipes of O2 with an inert gas such as N2, followed by filling the pipes with deoxygenated water generated “on the fly” as the water enters a building, using one or more Gas Transfer Membrane (GTM) devices and N2 gas. The GTM device eliminates the need for a water reuse tank and its associated pipes, valves, recirculation regimen, and the like. Water is pumped directly from the building water supply to a GTM device, where it is deoxygenated to very low O2 levels—such as below 300 ppb (parts per billion). The deoxygenated water then flows directly into the O2-purged pipes of the FPS. When the FPS is drained for testing or repair, the deoxygenated water may be discharged, and replaced, upon return to service of the FPS, with water freshly deoxygenated from the building supply as the FPS piping is filled.

Abstract: A fire suppression composition includes starch, a pseudo-plastic, high yield, suspending agent, and agglomerating material.

Abstract: A portable doorway recreation device for use on a doorway frame comprises an L-shaped frame. A first horizontal elongate bar is attached to a riser of the L-shaped frame and a second horizontal elongate bar is attached to a base of the L-shaped frame. A vise clamp is operatively associated with the second elongate bar, wherein with the first elongate bar sitting on a top of the doorway frame on a first wall side and the second elongate bar operatively associated with a second wall side, the vise clamp is configured to receive a portion of the first and second wall sides to prevent movement of the second elongate bar away from the second wall side.